CCR5 and breast cancer: The secretion of the chemokine CCL5/RANTES (Regulated upon Activation, Normal T Cell Expressed and Presumably Secreted) from MSCs is increased by breast cancer cells, which then enhances in turn their motility and dissemination through the chemokine receptor CCR5 [42, 43].